Letter to the Editor

Page 58

Posts about this type

Underpowered Repetitive Transcranial Magnetic Stimulation Might Not Be an Effective Antidepressant Treatment

April 15, 2005

George Kirov, John Tredget, Emma Dunn, et al

Letter to the Editor

Warning: Psychiatry Can Be Hazardous to Your Mental Health

April 1, 2005

Christopher White

Letter to the Editor

A Case Report of Zolpidem-Induced Somnambulism

April 1, 2005

Ashish Sharma, Vijay K. Dewan

Letter to the Editor

Interferon-α Treatment of Hepatitis C Patients With Psychiatric Illness: Evidence-Based Risk-Benefit Assessment

April 1, 2005

Muhamad Aly Rifai

Letter to the Editor

Antipsychotic Medication and Diabetes Mellitusrs

March 15, 2005

Leslie L. Citrome

Letter to the Editor

Cholesterol and Lithium Levels Were Correlated but Serum HDL and Total Cholesterol Levels Were Not Associated With Current Mood State in Bipolar Patients

March 15, 2005

Carmen Diaz-Sastre, Maria M. Perez-Rodriguez, Alberto Cebollada, et al

Letter to the Editor

Increased Efficacy With Addition of Clozapine to Aripiprazole: Alternative Explanations

March 15, 2005

John R. DeQuardo

Letter to the Editor

Lithium Dosing Schedule and Renal Insufficiency

March 15, 2005

Eric G. Smith

Letter to the Editor

Reply to "Antipsychotic Medication and Diabetes."

March 15, 2005

Dan Cohen, Ronald P. Stolk

Letter to the Editor

Reply to 'Increased Efficacy With Addition of Clozapine to Arpipipazole: Alternative Explanations."

March 15, 2005

Sabina Lim

Letter to the Editor

"Reply to Lithium Dosing Schedule and Renal Isufficiency"

March 15, 2005

Elie Lepkifker

Letter to the Editor

"Reply to Single Versus Multiple Daily Dosing of Lithium: Renal Effects

March 15, 2005

Elie Lepkifker

Letter to the Editor

Serious Rash With Lamotrigine After Carbamazepine Discontinuation: A Case Report

March 15, 2005

Anton A. Subuh Surja, Kathryn E. Brotzge, Rif S. El-Mallakh

Letter to the Editor

Single Versus Multiple Daily Dosing of Lithium: Renal Effects

March 15, 2005

Chekkera Shammi

Letter to the Editor

A Case of Complex Movement Disorder Induced by Fluoxetine With Management of Dystonia by Botulinum Toxin Type A

February 15, 2005

J. Chen, David M. Swope

Letter to the Editor

Diabetes Mellitus During Olanzapine and Quetiapine Treatment in Japan

February 15, 2005

Dan Cohen

Letter to the Editor

Obesity and Mood Disorders: The Complex Problem of Insight

February 15, 2005

Claudia Ravaldi, Edoardo Barboni, Massimo Lai, et al

Letter to the Editor

Olanzapine-Induced Hyperprolactinemia and Galactorrhea Reversed With Addition of Bromocriptine: A Case Report

February 15, 2005

David E. Miller, C. Simon Sebastian

Letter to the Editor

New Onset of Diabetes Mellitus With Ziprasidone: A Case Report

February 15, 2005

Pablo Sánchez-Barranco

Letter to the Editor

Resolution of Ziprasidone-Related Tardive Dyskinesia With a Switch to Aripiprazole

February 15, 2005

Ashish Sharma, Sriram Ramaswamy, Vijay K. Dewan

Letter to the Editor

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics.

January 15, 2005

James L. Karagianis, Eduardo Dunayevich

Letter to the Editor

Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome."

January 15, 2005

Jambur Ananth

Letter to the Editor

Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients

January 15, 2005

S. Tziporah Cohen, Daphne Rulf, Ronald Pies

Letter to the Editor

Interactions of Cyclobenzaprine and Tricyclic Antidepressants

January 15, 2005

Nicholas Z. Rosenlicht, Kristin P. Riley-Lazo

« 1 … 56 57 58 59 60 … 86 »

Letter to the Editor

Underpowered Repetitive Transcranial Magnetic Stimulation Might Not Be an Effective Antidepressant Treatment

Warning: Psychiatry Can Be Hazardous to Your Mental Health

A Case Report of Zolpidem-Induced Somnambulism

Interferon-α Treatment of Hepatitis C Patients With Psychiatric Illness: Evidence-Based Risk-Benefit Assessment

Antipsychotic Medication and Diabetes Mellitusrs

Cholesterol and Lithium Levels Were Correlated but Serum HDL and Total Cholesterol Levels Were Not Associated With Current Mood State in Bipolar Patients

Increased Efficacy With Addition of Clozapine to Aripiprazole: Alternative Explanations

Lithium Dosing Schedule and Renal Insufficiency

Reply to "Antipsychotic Medication and Diabetes."

Reply to 'Increased Efficacy With Addition of Clozapine to Arpipipazole: Alternative Explanations."

"Reply to Lithium Dosing Schedule and Renal Isufficiency"

"Reply to Single Versus Multiple Daily Dosing of Lithium: Renal Effects

Serious Rash With Lamotrigine After Carbamazepine Discontinuation: A Case Report

Single Versus Multiple Daily Dosing of Lithium: Renal Effects

A Case of Complex Movement Disorder Induced by Fluoxetine With Management of Dystonia by Botulinum Toxin Type A

Diabetes Mellitus During Olanzapine and Quetiapine Treatment in Japan

Obesity and Mood Disorders: The Complex Problem of Insight

Olanzapine-Induced Hyperprolactinemia and Galactorrhea Reversed With Addition of Bromocriptine: A Case Report

New Onset of Diabetes Mellitus With Ziprasidone: A Case Report

Resolution of Ziprasidone-Related Tardive Dyskinesia With a Switch to Aripiprazole

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics.

Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome."

Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients

Interactions of Cyclobenzaprine and Tricyclic Antidepressants

ELSEWHERE:

FOLLOW US:

Letter to the Editor

Posts about this type

Underpowered Repetitive Transcranial Magnetic Stimulation Might Not Be an Effective Antidepressant Treatment

Warning: Psychiatry Can Be Hazardous to Your Mental Health

A Case Report of Zolpidem-Induced Somnambulism

Interferon-α Treatment of Hepatitis C Patients With Psychiatric Illness: Evidence-Based Risk-Benefit Assessment

Antipsychotic Medication and Diabetes Mellitusrs

Cholesterol and Lithium Levels Were Correlated but Serum HDL and Total Cholesterol Levels Were Not Associated With Current Mood State in Bipolar Patients

Increased Efficacy With Addition of Clozapine to Aripiprazole: Alternative Explanations

Lithium Dosing Schedule and Renal Insufficiency

Reply to "Antipsychotic Medication and Diabetes."

Reply to 'Increased Efficacy With Addition of Clozapine to Arpipipazole: Alternative Explanations."

"Reply to Lithium Dosing Schedule and Renal Isufficiency"

"Reply to Single Versus Multiple Daily Dosing of Lithium: Renal Effects

Serious Rash With Lamotrigine After Carbamazepine Discontinuation: A Case Report

Single Versus Multiple Daily Dosing of Lithium: Renal Effects

A Case of Complex Movement Disorder Induced by Fluoxetine With Management of Dystonia by Botulinum Toxin Type A

Diabetes Mellitus During Olanzapine and Quetiapine Treatment in Japan

Obesity and Mood Disorders: The Complex Problem of Insight

Olanzapine-Induced Hyperprolactinemia and Galactorrhea Reversed With Addition of Bromocriptine: A Case Report

New Onset of Diabetes Mellitus With Ziprasidone: A Case Report

Resolution of Ziprasidone-Related Tardive Dyskinesia With a Switch to Aripiprazole

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics.

Dr. Ananth Replies to Drs. Carroll and Lee "Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome."

Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients

Interactions of Cyclobenzaprine and Tricyclic Antidepressants

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles